Tag Archives: Covid-19

Science Podcast: Covid Questions Answered, Rocky Planet Formation

Science Staff Writer Jon Cohen joins host Sarah Crespi to take on some of big questions about the COVID-19 vaccines, such as: Do they stop transmission? Will we need boosters? When will life get back to “normal.” 

Sarah also talks with Anders Johansen, professor of planetary sciences and planet formation at the University of Copenhagen, about his Science Advances paper on a new theory for the formation of rocky planets in our Solar System. Instead of emerging out of ever-larger collisions of protoplanets, the new idea is that terrestrial planets like Earth and Mars formed from the buildup of many small pebbles.

Covid-19 Infographic: The Top Vaccines Most Widely Used Around The World

Eight different Covid-19 vaccines are currently being used around the world and just over 172 million people have received their first dose, 2.2 for every 100 people. All of the vaccines being used require two shots but that is set to change with Johnson & Johnson’s JNJ+0.3%JNJ+0.3% one-shot vaccine expected to gain regulatory approval for use in the United States within weeks. As it stands, the first Covid-19 vaccine to be authorized for use in the U.S. is also the most widely used shot globally, according to information from website Our World in Data reported by The New York Times.

Read more

Morning News Podcast: Economic Stimulus Focus, Covid Cases Fall, Russia

With impeachment finished, Congress now returns to focusing on President Biden’s economic stimulus plan. But why do some economists say it could be too much?

Also, daily coronavirus cases are falling across the U.S. and the pace of vaccinations is increasing. And, in a change from the massive demonstrations last month, Russians in multiple cities used their cellphone flashlights to show their support for jailed opposition leader Alexei Navalny.

Covid-19: Race To Update Vaccines For Variants

Just two months ago, the incredible performance of new vaccines from Moderna and Pfizer had people cheering for an imminent end to the pandemic. But an onslaught of fast-spreading and potentially dangerous mutations of the virus changed that. 

 So now, even as pharma companies ramp up production in the early stages of a massive rollout, they are racing to retool their vaccine strategies. Robert Langreth reports that booster shots could give drugmakers a lucrative new revenue stream.

Analysis: ‘Can Air Flights Go Green?’ (Video)

Covid-19 has caused the worst crisis in aviation’s history. Is this the industry’s moment for a green reset—and which technologies offer the best hope?

Morning News Podcast: 2nd Trump Impeachment, Covid Variant Concerns

The second impeachment trial of former President Donald Trump begins this week as Republicans and his legal team argue the impeachment is unconstitutional. 

And, South Africa has paused a planned deployment of a coronavirus vaccine from AstraZeneca after a study there showed it may be less effective against a new strain of the virus detected there. Also, how worried are U.S. health officials about variant strains of the virus in the U.S.?

Covid Vaccine: ‘What Went Wrong With U.S. Rollout’

The U.S. coronavirus rollout has been anything but smooth. States are reporting limited supply of vaccines, leading them to delay appointments and close clinics to the public. Some states lack staff and essential resources to get the job done. With little guidance from the previous White House administration on how to effectively administer vaccines, it’s up to states and local health officials to get the job done. President Joe Biden announced the administration will buy 200 million more vaccines and institute a national vaccine program to vaccinate 100 million doses in his first 100 days. But can it be done? Here’s what went wrong with the U.S. coronavirus vaccine rollout and how a new White House plans to turn things around.